Related Experiment Video
Updated: Jul 2, 2026
Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay
Published on: April 3, 2009
[Study on the chemosensitivity test of human gastric cancer using the MTT assay]
1Department of General Surgery, First Affiliated Hospital, WCUMS, Chengdu 610041, China.
Objective:
This study was conducted to investigate the chemosensitivity of gastric carcinoma.
Methods:
112 cases of fresh human gastric cancer samples were obtained for drug sensitivity testing using MTT.
Results:
The sensitivity sequence of antitumor agents was 5-Fu, DDP, MMC, etc. On the other hand, the sensitivity was relative to pathology and individual differences.
Conclusion:
The MTT assay is an accurate system for determination of the chemosensitivity of tumor cells.
Insights
The MTT assay accurately determines gastric carcinoma chemosensitivity. Drug effectiveness varied based on individual patient pathology and specific antitumor agents like 5-Fu.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Context:
- Gastric carcinoma presents a significant global health challenge.
- Understanding tumor cell chemosensitivity is crucial for effective treatment strategies.
Purpose:
- To investigate the chemosensitivity of human gastric cancer cells.
- To evaluate the efficacy of the MTT assay in determining drug sensitivity.
Summary:
- 112 fresh human gastric cancer samples were analyzed using the MTT assay for drug sensitivity.
- The study identified a sensitivity sequence for antitumor agents, with 5-Fluorouracil (5-Fu), Cisplatin (DDP), and Mitomycin C (MMC) showing differential efficacy.
- Chemosensitivity was found to be influenced by individual pathological differences.
Impact:
- The MTT assay provides a reliable method for assessing gastric cancer chemosensitivity.
- Results can inform personalized treatment approaches for gastric carcinoma patients.
- This research contributes to the development of targeted chemotherapy regimens.
